| HS Code | 119255 |
| Iupac Name | (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
| Molecular Formula | C31H35ClO9 |
| Molecular Weight | 587.05 g/mol |
| Cas Number | Unavailable |
| Appearance | White to off-white solid |
| Solubility | Soluble in organic solvents (e.g., dichloromethane, chloroform), low solubility in water |
| Boiling Point | Decomposes before boiling |
| Purity | Typically >98% (when synthesized) |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Smiles | CCOC1=CC=C(C=C1)CC2=CC(=C(C=C2Cl)C3O[C@@H]([C@H]([C@H]([C@@H](O3)OC(=O)C)OC(=O)C)OC(=O)C)COC(=O)C |
| Inchi | InChI=1S/C31H35ClO9/c1-5-39-23-8-6-20(7-9-23)15-21-13-24(33)19(12-22(21)16-40-30(34)36)31-28(38-29(35)37)27(26(25(31)41-17(2)32)42-18(3)34)43-14-10-11-14/h6-9,12-13,26-28,31H,5,10-11,14-16H2,1-4H3/t26-,27-,28+,31-/m0/s1 |
| Logp | Estimated 4.1 |
As an accredited (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, 5 grams, tightly sealed with a tamper-evident cap; labeled with chemical name, structure, and hazard symbols. |
| Container Loading (20′ FCL) | 20′ FCL: Securely loaded, sealed drums or HDPE containers, each properly labeled; net weight maximized per shipping regulations and safety standards. |
| Shipping | This chemical is shipped in sealed, inert containers under cool, dry conditions to ensure stability and prevent contamination. Packages are clearly labeled with hazard information and comply with international shipping regulations for chemicals. Transport is handled by licensed carriers specializing in hazardous or sensitive materials, with tracking and documentation provided throughout transit. |
| Storage | Store **(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate** in a tightly sealed container, protected from light and moisture, at 2–8 °C (refrigerated conditions). Keep away from strong acids, bases, and oxidizing agents. Ensure storage in a well-ventilated area with appropriate chemical labeling and secondary containment to prevent accidental spills or contamination. |
| Shelf Life | Shelf life: Store at 2-8°C, protected from light and moisture; stable for at least 2 years under proper conditions. |
As a manufacturer, we deliver (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate to highly specialized downstream industries. This intermediate supports strict production flows in pharmaceutical, agrochemical, specialty chemical, and advanced material synthesis, among others. Each application scenario is governed by industry regulations, precise formulation guidelines, and is integrated at specific processing stages, ensuring quality and compliance for high-value finished products.
Our compound is used in the synthesis of advanced pharmaceutical intermediates targeting selective estrogen receptor modulators. Downstream pharmaceutical companies incorporate it into multi-step synthesis, benefiting from its stereochemical specificity and functional group utility. Its acetoxy and benzyl functionalities allow clean conversions and effective protection/deprotection cycles, supporting production of API cores for SERM classes. Each batch strictly follows cGMP and ICH Q7 guidelines, and our QC team provides detailed analytical support for regulatory filings.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Downstream crop protection formulators incorporate this material in the multi-step production of complex herbicide and fungicide molecules, where the protected tetrahydropyran scaffold provides selectivity and traceability through synthetic transformations. Our product aligns with compliance requirements for industrial pesticide intermediate controls and supports reproducibility in scale-up projects under ISO management.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Specialty and fine chemical manufacturers leverage this acetylated tetrahydropyran derivative as a protected glycoside precursor for high-value carbohydrate and oligosaccharide synthesis. Its multi-acetate functionality permits selective deprotection under mild conditions, optimizing yield and purity. This enables downstream designers to access structurally complex sugars for food, diagnostic, and biotechnological applications under validated HACCP and quality protocols.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Materials science and polymer developers use this compound as an advanced monomer or co-monomer for engineering high-performance materials. The aromatic and acetoxylated structural motifs can be leveraged for introducing targeted functionality into specialty polymers. Our quality assurance processes align with ISO and ASTM requirements for polymer raw material production, supporting consistent performance in downstream extrusion or molding steps.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Contract research and manufacturing organizations (CROs/CMOs) rely on this specialized material for custom synthesis of chiral and structurally diverse small molecules. The defined stereochemistry and acetoxy pattern are essential for rapid lead diversification, SAR studies, and advanced stage research projects. Our supplied intermediates fulfill stringent documentation and traceability demands under confidentiality and regulatory norms common in global medicinal chemistry workflows.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8618005193850
Email: sales8@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years in the lab reveal patterns. Certain molecules just allow for more flexibility, more possibilities at the bench. Among carbohydrate-derived intermediates, the compound (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate has proven itself through repeated custom synthesis jobs and in-house drug development pilots. Each time, the molecular arrangement — combining several acetoxy functions with a versatile pyran backbone — has allowed experienced chemists and junior bench staff alike to realize efficient downstream transformations, find new routes, or troubleshoot bottleneck steps with reliable yields and minimal side reactions.
The backbone here draws on monosaccharide chemistry, but its 6-position is tailored with a 4-chloro-3-(4-ethoxybenzyl)phenyl moiety. It’s not a routine modification — the shift in electron density tweaks how the ring reacts with nucleophiles and electrophiles. One lesson learned: that selectivity can help streamline late-stage functionalization steps. In the real world, fewer protecting group manipulations translate directly into lower cycle times, lower raw material costs, less downtime separating stubborn byproducts. Productivity in our plant doesn’t hinge on one large breakthrough, but on minimizing these headaches year after year.
This triacetate form also delivers stability on the shelf without commiting you to just one chemical reactivity. We see both research and production chemists take advantage of this: the acetoxy groups protect and activate, yet can be removed under both mild basic and acidic conditions. It’s no surprise our partners often choose this protected variant over an unprotected pyran ring — the balance between reactivity and stability lines up with real-world process requirements, especially for multi-step API explorations where time and batch integrity matter.
Long before formal specification sheets, we scrutinized every batch for color, solubility (both aqueous and organic), melting point, and chemical purity using NMR, HPLC, GC-MS, and IR. A tight control of impurities (usually residual starting materials or side-acetylated isomers) allows us to support synthetic chemists in scaling up — small differences at a few grams can balloon into drastic yield swings at the kilo scale. Internally, we aim for a purity of >98% by HPLC, minimizing both residual chlorinated organics and particulate contamination. Elevated optical activity confirms correct stereochemical assignment batch after batch.
During early development, it became clear that appearance matters too. Early feedback from project chemists shaped our oxidation sequence, yielding a consistently off-white crystalline solid, easily handled on scale. Granularity, flow, and resistance to caking reduce headache downstream, especially for automated dispensing or formulation blending.
This molecule didn’t originate in a catalog. It surfaced from repeated demand for robust intermediates during carbohydrate modification projects, especially when teams wanted to incorporate arylated groups onto pyran rings — without first cleaving off protecting groups that introduced more variables than they solved. We refined our own method to couple a 4-chloro-3-(4-ethoxybenzyl)phenyl group onto a properly protected tetrahydropyran. Time in the pilot plant helped us appreciate which steps limited scalability — temperature lability, byproduct formation, and isolation difficulties — and success meant finding solvent/temperature combinations that delivered batch reproducibility.
Bench chemists in both pharma and specialty chemical development see value in this intermediate for peptide mimetic synthesis and custom carbohydrate chemistry. The multiple acetoxy groups create branching points for regioselective deprotection. Our formulation avoids unknown byproducts, supporting process reproducibility — a lesson only learned after trouble-shooting yields in scale ups with partners who tried using off-brand or underspecified imports that failed in the acidolysis or hydrogenolysis steps.
Real-world conditions rarely match textbook cases. That’s why our focus has always remained on batch consistency, solvent compatibility, and stability. This molecule remains free-flowing at normal storage humidity, packs densely without forming hard crusts, and dissolves smoothly in classical solvents—ethyl acetate, methanol, dichloromethane, and THF, among others. That compatibility enables quick fit into intermediate stages in multi-step syntheses — one insight that emerged early from feedback was that bottlenecks often arose not from the main reaction, but from issues during work-up, filtration, or transfer between steps. Maintaining low ash and trace ion content through careful washing and drying protocols led to improved downstream purity and fewer headaches for QA and regulatory documentation.
Our team avoids excessive micronization or over-blending, instead relying on controlled crystallization and low-energy drying under vacuum. The end result flows smoothly onto the next process — and doesn’t clog lines. Experienced plant operators asked for this after encountering bridging in automated material feeders with more amorphous or oil-contaminated alternatives. Listening to actual process engineers improved not just the quality but the experience of handling the product in a working facility.
Most requests come from pharmaceutical, agrochemical, and specialty research groups. This protected tetrahydropyran forms a core building block for glycosylation reactions, protected sugar analog synthesis, and preparations where clean selective deprotection matters. The aryl chloro-ethoxybenzyl motif carved out a unique utility for structurally complex molecule projects where introduction of both electron-rich and electron-deficient regions within the same backbone are desirable. It is not uncommon to see contract research organizations and startups order multi-kilo quantities for project-based research as well as long-term development of potential lead candidates for clinical trials.
We’ve also seen demand spike for advanced oligosaccharide constructs, especially where traditional monosaccharide building blocks fall short on regioselectivity or controllable transformations. The molecular design enables selective functionalization at multiple positions, enabling researchers to experiment, optimize, and develop compounds that shift the boundaries of therapeutic targeting or materials performance. Over years of dispatching this product, our technical support group has shared dozens of protocol tweaks and best practices to optimize coupling and deprotection sequences. Sometimes, the difference between a successful step and a frustrating bottleneck involves subtle changes in timing or order of reagent addition — these practical details, collected through countless customer conversations, shape our evolving guidance for new users.
Many carb-protected pyran intermediates on the market favor simple benzyl or methyl substituents. Each end up more narrow in their applicability, especially for library generation or medicinal chemistry where diversity at the aryl position predicts better downstream results. The inclusion of the orthogonal 4-chloro-3-(4-ethoxybenzyl)phenyl group expands the possibilities, allowing access to more elaborate derivatives via either electrophilic or nucleophilic aromatic substitutions on the aryl ring following glycosylation or functional group manipulation. This extra handle has proved decisive for several industrial clients scripting out multi-step, patent-sensitive routes.
Some competitive products skip one or two acetate protections or substitute with benzoyl for price. Years of hands-on testing show that these sacrifices lead to significantly more side product generation during reaction work-ups, challenging chromatography, and waste stream contamination due to incomplete removal of side-benzoates or over-deprotected fractions. Our experience with in-process cleaning and digital QA monitoring reveals that these minor differences routinely translate into hours of lost work, additional solvent usage, and even costly analytical reruns. Our decision to maintain a tight specification on acetyl completeness reflects the real costs avoided by our customers.
Expanding chemical diversity while maintaining performance remains a tightrope in both our industry and at the bench. Much of the value we bring comes not only from product consistency, but from seeing how application-focused partnerships lead to new synthetic insights. Across repeated process development projects with industry partners, having this protected pyran intermediate on hand enabled not only the intended coupling chemistry, but creative offshoots in late-stage derivatization. Sometimes, steric hindrance or functional group incompatibility with more basic intermediates caused extensive rework; switching to this triacetate variant often resolved these roadblocks, letting teams meet regulatory milestone timelines.
Our internal process chemists drive risk-mitigation efforts by batch testing solvent compatibility, heat stability, and shelf-life over months. For shipments longer than two weeks or to high-humidity climates, sealed composite drums lined with polyethylene shield the product from water uptake and cross-contamination — practices refined after replacing lost batches for a customer in the tropics. We offer documentation on trace byproducts, RLMS mass data, and NMR trace impurity assignments, helping both QA managers and regulatory teams build out compliant batch records.
We count on feedback from technical staff at both small research firms and large global manufacturing partners. Over time, it became evident that slight modifications in solvent systems for precipitation, as well as tweaks in crystallization cooling rates, yield cleaner intermediates with higher recovery rates. These changes stem directly from collaborative troubleshooting — for instance, plant managers flagged scale-up filtration bottlenecks, leading to adjustments which improved throughput and reduced downtime.
Our technical teams work closely with QC labs to integrate next-generation diagnostics — real-time HPLC, orthogonal purity checks, and improved microbalance handling at the gram and kilogram scale. The payoff comes not only in in-house process reliability but in fewer queries from partners who receive technical support based on well-documented batch-to-batch records, not assumptions or blanket COAs.
Being a manufacturer, not a broker or trading agent, matters. Our facilities operate batch and semi-continuous reactors, validated through repeated regulatory inspections. Each synthesis follows the protocol evolved for reproducibility — tested internally before ever accepting scale-up orders. QA/QC staff work alongside synthesis teams, and we keep a constant loop with external analytical labs for any new impurity profiles.
Every customer challenge — whether it’s an unexpected side product, an equipment delay, or a revised protocol from their R&D side — prompts us to revisit assumptions and continuously refine our approach. We’ve learned that delivering clean, clearly labeled, and documentation-rich shipments doesn’t just meet compliance obligations — it cuts costs, reduces miscommunication, and drives trust over repeat cycles.
As industry requirements shift and new synthetic routes become the norm, adaptable intermediates like this triacetate remain essential. Addition of functionalized aryl groups to carbohydrate scaffolds opens novel avenues in medicinal, diagnostic, and material chemistry. Our commitment to reliable, scalable, and high-purity production has shaped not just our internal standards but influenced broader protocol improvements for end users.
Experts collaborating across industries point repeatedly to the need for robust, scalable intermediates that fill not only today’s needs but adapt as new transformations come online. Learning from each batch and every user story, we strengthen our foundation of technical excellence — not just as a promise, but as the lived experience of hundreds of successful projects.